Skip to content

Uterine Tourniquet at Open Myomectomy

Triple Tourniquet vs. Single Tourniquet at Open Myomectomy to Reduce Blood Loss: A Prospective Randomised Controlled Trials

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02049242
Enrollment
48
Registered
2014-01-30
Start date
2014-01-31
Completion date
2014-12-31
Last updated
2014-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myomectomy, Uterine Leiomyoma

Keywords

Hemorrhage, Leiomyoma, Myofibroma, Uterine Myomectomy, Tourniquet

Brief summary

The aim of study is to compare triple tourniquet vs. single tourniquet to reduce blood loss at open myomectomy.

Detailed description

Single tourniquet is applied to uterine isthmus to occlude uterine arteries. Triple tourniquet is applied to both infundibulopelvic ligaments and uterine isthmus.

Interventions

Triple tourniquet consist of two tourniquet applied both infundibulopelvic ligaments and one uterine isthmus to occlude the left and right ovarian vessels and to occlude the uterine arteries. For this purpose, a small opening is made in the avascular place of the broad ligament on either side of the uterine isthmus superior to the uterine vessels. A pediatric Foley catheter is threaded through the two holes and tied tightly anteriorly around the cervix at the level of the internal os. Through the same openings in the broad ligament each side a Foley catheter looped around the infundibulopelvic ligament lateral to the fallopian tube and ovary.

Single tourniquet is tourniquet applied uterine isthmus to occlude the uterine arteries. For this purpose, a small opening is made in the avascular place of the broad ligament on either side of the uterine isthmus superior to the uterine vessels. A pediatric Foley catheter is threaded through the two holes and tied tightly anteriorly around the cervix at the level of the internal os.

Sponsors

Erzurum Nenehatun Kadın Doğum Hastanesi
CollaboratorUNKNOWN
Ataturk University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 48 Years
Healthy volunteers
Yes

Inclusion criteria

* uterine myoma \>12 weeks

Exclusion criteria

* Pedunculated myoma, broad ligament myoma * Hb\<10.5 g /dl

Design outcomes

Primary

MeasureTime frameDescription
Estimating blood loss at the end of myomectomy15 minutes postoperatiflySurgical blood loss will be estimated by sum of the volume of suction fluid and blood loss quantitated by gravimetric method. During surgery, if it is possible, irrigation will not be done, surgical sponge and compress will not be used. * Suction fluid will be measured at the end of operation and volume of irrigation fluid will be subtracted from total suction volume. * Surgical drapes, sponges and towels will be weighted before and just after surgery. The blood loss will be estimated as differences in gram by weighing when 1ml blood supposed as 1 gr.

Secondary

MeasureTime frameDescription
A change in hemoglobinAt baseline and 48 hours after surgery
The amount of transfusions7 DaysErythrocyte transfusions transfusion will be allowed when haemoglobin dropped below 8 g/dL.
Volume in drains7 daysDrain will be removed when discharge drops below 50 ml/day
Anti-Mullerian Hormone levels variation6 weeksAnti-Mullerian Hormone levels before and 6 months after surgery

Other

MeasureTime frameDescription
Tourniquet time5 minutes after tourniquet removed
Total operation time5 minutes post operatively
Peri-operative complications6 weeks postoperativelyIncluding but not limited to fever, pelvic infections, wound infections.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026